YOKNEAM ILLIT, Israel, Nov. 16, 2022 /PRNewswire/ -- A study published in eJHaem Journal of Hematology in August 2022, compared PixCell Medical's FDA-cleared Point-of-Care 5-part differential CBC ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果当前正在显示可能无法访问的结果。
隐藏无法访问的结果